CRDF Cardiff Oncology, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 11, 2026
$1.12
· % 处于52周区间
· 高于低点
· 至高点
$0.7652周低点
$3.3152周高点
市值 (MRQ)
$77M
P/E (TTM)
-1.9
EPS (TTM)
$-0.60
收入 (TTM)
$508.0K
CRDF 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.12
市值 (MRQ)
$77M
P/E (TTM)
-1.9
EPS (TTM)
$-0.60
收入 (TTM)
$508.0K
ROE (TTM)
-94.1%
52周区间
$1–$3
CRDF 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2019年2月20日 | 1-for-6 | 反向 |
| 2018年6月4日 | 1-for-12 | 反向 |
| 2012年5月30日 | 1-for-6 | 反向 |
| 2004年7月27日 | 111-for-1 | 正向 |
10年表现 收入、净利润、利润率和每股收益趋势
收入$593.0K2016-12-31 → 2025-12-31
EPS$-0.692016-12-31 → 2025-12-31
自由现金流$-38M2016-12-31 → 2025-12-31
净利率-7884.1%2016-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | CRDF | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -1.95年均值 ≈-4.0 | ≈-4.0 | · | · | |
| P/S (TTM) | 151.05年均值 ≈349.3 | ≈349.3 | 70.6 | 估值过高 | |
| 市净率 (MRQ) | 2.95年均值 ≈2.2 | ≈2.2 | 2.3 | 估值过高 | |
| Price / FCF (股价/自由现金流) | -2.05年均值 ≈-5.5 | ≈-5.5 | · | · | |
| Price / Cash Flow (市现率) | -2.05年均值 ≈-5.5 | ≈-5.5 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 1.75年均值 ≈2.2 | ≈2.2 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | CRDF | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -8320.1%5年均值 ≈-8612.0% | ≈-8612.0% | -749.2% | 弱 | |
| 息税折旧摊销前利润率 (TTM) | -8251.0%5年均值 ≈-8534.2% | ≈-8534.2% | -749.2% | 弱 | |
| Pretax Margin (税前利润率) | -7732.0% | · | -1847.2% | 弱 | |
| 净利润率 (TTM) | -7884.1%5年均值 ≈-8156.6% | ≈-8156.6% | -767.3% | 弱 | |
| ROA (TTM) | -70.8%5年均值 ≈-39.9% | ≈-39.9% | -26.7% | 弱 | |
| ROE (TTM) | -94.1%5年均值 ≈-53.8% | ≈-53.8% | -61.5% | 弱 | |
| ROIC | -107.9% | · | -55.9% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | CRDF | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 3.35年均值 ≈10.9 | ≈10.9 | 5.0 | 低流动性 | |
| 速动比率 (MRQ) | 3.25年均值 ≈10.6 | ≈10.6 | 3.3 | 持平 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | CRDF | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -13.2%5年均值 ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 15.4%5年均值 ≈16.5% | ≈16.5% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 10.1% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | CRDF | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.05年均值 ≈0.0 | ≈0.0 | 0.0 | 弱 | |
| Receivables Turnover (应收账款周转率) | 1.25年均值 ≈1.0 | ≈1.0 | · | · | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$19.8K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
5.5%
下次报告
十一月 04, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 七月 27, 2026 | $-0.14 | $-0.16 | 14.9% |
| 2026年3月31日 | 五月 14, 2026 | $-0.18 | $-0.14 | -31.1% |
| 2025年12月31日 | $-0.11 | $-0.19 | 42.6% | |
| 2025年9月30日 | $-0.17 | $-0.21 | 18.5% | |
| 2025年6月30日 | $-0.21 | $-0.20 | -6.9% | |
| 2025年3月31日 | $-0.20 | $-0.19 | -5.3% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $593.0K | $683.0K | $488.0K | $386.0K | $359.0K | $366.0K | $244.6K | $378.3K | $505.4K | $381.1K | $312.8K | $280.2K | |
| Cost of Revenue | · | · | · | · | · | · | $0 | $597.5K | $2M | $2M | $629.2K | $15.4K | |
| R&D Expense | · | · | · | $27M | $17M | $11M | · | · | · | · | · | · | |
| SG&A Expense | $14M | $12M | $13M | $13M | $12M | $8M | $6M | $8M | $14M | $11M | $8M | $6M | |
| Operating Expenses | $50M | $49M | $46M | $40M | $29M | $19M | $17M | $17M | $26M | $41M | $26M | $15M | |
| Operating Income | $-49M | $-49M | $-45M | $-40M | $-29M | $-19M | $-17M | $-17M | $-26M | $-40M | $-25M | $-15M | |
| Interest Expense | · | · | · | · | $0 | $2.0K | $0 | $25.4K | $1M | $2M | $2M | $843.3K | |
| Interest Income | $3M | $3M | $4M | $2M | $264.0K | $90.0K | $234.2K | $219.4K | $147.9K | $298.8K | · | · | |
| Other Non-op | $5.0K | $-39.0K | $-98.0K | $1M | $564.0K | $-221.0K | · | · | · | · | · | · | |
| Pretax Income | $-46M | $-45M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-46M | $-45M | $-41M | $-39M | $-28M | $-19M | $-16M | $-16M | $-25M | $-39M | $-27M | $-14M | |
| EPS (Basic) | $-0.69 | $-0.95 | $-0.93 | $-0.89 | $-0.73 | $-1.08 | · | $-8.26 | $-51.76 | $-1.30 | $-1.05 | $-0.76 | |
| EPS (Diluted) | $-0.69 | $-0.95 | $-0.93 | $-0.89 | $-0.73 | $-1.08 | · | $-8.26 | $-51.76 | $-1.37 | $-1.21 | $-0.88 | |
| Shares (Basic) | 66,841,000 | 47,650,000 | 44,677,000 | 43,600,000 | 39,030,000 | 20,875,000 | 5,973,906 | 2,330,180 | 481,672 | 30,174,838 | 26,201,713 | 18,904,280 | |
| Shares (Diluted) | 66,841,000 | 47,650,000 | 44,677,000 | 43,600,000 | 39,030,000 | 20,875,000 | · | 2,330,180 | 481,672 | 30,281,263 | 26,452,165 | 19,071,112 | |
| EBITDA | $-49M | $-48M | $-45M | $-40M | $-28M | $-19M | $-16M | $-16M | $-24M | $-39M | $-25M | $-15M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $51M | $22M | $16M | $12M | $131M | $10M | $11M | $8M | $14M | $67M | $67M | |
| Short-term Investments | $41M | $40M | $53M | $89M | $129M | $0 | · | · | $0 | $24M | $0 | · | |
| Receivables | $182.0K | $773.0K | $288.0K | $771.0K | $535.0K | $320.0K | $203.5K | $167.8K | $77.1K | $100.5K | $98.7K | $56.7K | |
| Prepaid Expense | $2M | $3M | $2M | $5M | $5M | $2M | $955.0K | $1M | $1M | $956.6K | $789.3K | $369.3K | |
| Current Assets | $60M | $95M | $77M | $111M | $146M | $133M | $11M | $13M | $9M | $39M | $68M | $28M | |
| PP&E (Net) | $578.0K | $898.0K | $1M | $1M | $382.0K | $624.0K | $877.8K | $1M | $2M | $4M | $3M | $840.4K | |
| PP&E (Gross) | $5M | $5M | $5M | $5M | $4M | $4M | $3M | $3M | $4M | $6M | $4M | $1M | |
| Accum. Depreciation | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $854.8K | $533.9K | |
| Other Non-current Assets | $549.0K | $69.0K | $1M | $1M | $239.0K | $404.0K | $157.6K | $102.8K | $389.9K | $1M | $374.0K | $336.7K | |
| Total Assets | $62M | $97M | $82M | $116M | $150M | $135M | $13M | $14M | $12M | $44M | $71M | $29M | |
| Accounts Payable | $8M | $5M | $2M | $2M | $1M | $1M | $656.3K | $664.8K | $825.2K | $1M | $1M | $747.8K | |
| Accrued Liabilities | $8M | $8M | $8M | $5M | $5M | $4M | $3M | $2M | $1M | $4M | $2M | $2M | |
| Short-term Debt | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Current Liabilities | $16M | $13M | $10M | $8M | $7M | $6M | $5M | $3M | $4M | $8M | $8M | $4M | |
| Capital Leases | $102.0K | $813.0K | $1M | $2M | $3M | $9.0K | $861.0K | $0 | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $156.0K | $128.4K | $42.0K | · | · | $0 | · | |
| Total Liabilities | $16M | $14M | $12M | $10M | $9M | $7M | $6M | $4M | $6M | $24M | $23M | $21M | |
| Common Stock | $7.0K | $7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $8.3K | $7.7K | $5.3K | $3.1K | $3.0K | $1.9K | |
| Paid-in Capital | $475M | $467M | $409M | $405M | $401M | $362M | $217M | $202M | $180M | $168M | $158M | $90M | |
| Retained Earnings | $-430M | $-384M | $-340M | $-298M | $-260M | $-231M | $-209M | $-192M | $-173M | $-148M | $-109M | $-81M | |
| AOCI | $50.0K | $34.0K | $-67.0K | $-395.0K | $-142.0K | $0 | · | · | $0 | $-10.8K | $0 | · | |
| Stockholders' Equity | $45M | $83M | $70M | $106M | $140M | $128M | $7M | $10M | $7M | $20M | $49M | $8M | |
| Liabilities + Equity | $62M | $97M | $82M | $116M | $150M | $135M | $13M | $14M | $12M | $44M | $71M | $29M | |
| Shares Outstanding | 68,305,000 | 66,524,000 | 44,677,000 | 44,677,000 | 41,964,000 | 36,781,000 | 8,593,633 | 3,831,879 | 733,217 | 30,696,791 | 29,737,601 | 18,915,793 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $364.0K | $404.0K | $398.0K | $236.0K | $451.0K | $466.0K | $494.2K | $859.5K | $1M | $1M | $378.7K | $234.8K | |
| Stock-based Comp | $6M | $5M | $5M | $4M | $3M | $2M | $884.9K | $2M | $4M | $8M | $4M | $2M | |
| Deferred Tax | $-9M | $-9M | $-9M | $24M | $-6M | $-4M | $-3M | $-4M | $13M | $-17M | $-11M | $-6M | |
| Restructuring | · | · | · | · | · | · | $0 | $664.7K | $2M | $790.4K | $0 | $0 | |
| Other Non-cash | $11M | $12M | $15M | $-24M | $8M | $5M | $5M | $4M | $-17M | $16M | $12M | $-706.9K | |
| Operating Cash Flow | $-38M | $-38M | $-31M | $-34M | $-23M | $-16M | $-13M | $-13M | $-23M | $-31M | $-22M | $-13M | |
| CapEx | $44.0K | $80.0K | $582.0K | $1M | $205.0K | $211.0K | $67.6K | $5.1K | $101.1K | $823.5K | $2M | $363.3K | |
| Investing Cash Flow | $1M | $14M | $36M | $38M | $-131M | $-211.0K | $-67.6K | $22.8K | · | · | · | · | |
| Debt Issued | · | · | · | · | $0 | $305.0K | $0 | · | $0 | $8M | $0 | $15M | |
| Net Debt Issued | · | · | · | · | $0 | $305.0K | · | $0 | $-15M | $-1M | $0 | $15M | |
| Stock Issued | $0 | $53M | · | $0 | $34M | $112M | $9M | $12M | $12M | $2M | $61M | $0 | |
| Net Stock Activity | $0 | $53M | · | $0 | $34M | $112M | $9M | $13M | $12M | $2M | $61M | · | |
| Financing Cash Flow | $3M | $54M | $0 | $75.0K | $35M | $137M | $12M | $16M | · | · | · | · | |
| Net Change in Cash | $-34M | $30M | $5M | $4M | $-119M | $121M | $-1M | $3M | · | · | · | · | |
| Taxes Paid | $1.0K | $1.0K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-38M | $-38M | $-31M | $-35M | $-23M | $-17M | $-13M | $-13M | $-23M | $-32M | $-24M | $-13M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -8256.3% | -7123.1% | -9305.7% | -10337.3% | -8037.6% | -5214.8% | -6817.8% | -4507.6% | -5064.4% | -10534.9% | -8079.5% | -5334.2% | |
| Net Margin | -7732.0% | -6651.7% | -8492.0% | -10026.9% | -7880.5% | -5275.1% | -6709.7% | -4351.1% | -4928.1% | -10287.8% | -8782.0% | -5113.0% | |
| Pretax Margin | -7732.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -8194.9% | -7064.0% | -9224.2% | -10276.2% | -7912.0% | -5087.5% | -6615.8% | -4280.4% | -4817.6% | -10254.2% | -7958.4% | -5250.4% | |
| ROA | -57.6% | -50.8% | -41.9% | -29.1% | -19.9% | -26.1% | -120.4% | -124.4% | -88.6% | -68.0% | -54.8% | -51.1% | |
| ROE | -88.2% | -68.7% | -56.2% | -35.3% | -20.6% | -23.9% | -235.0% | -136.8% | -189.6% | -114.5% | -96.3% | -99.7% | |
| ROIC | -107.9% | · | · | · | · | · | · | · | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 7.1 | 7.4 | 14.3 | 22.3 | 21.8 | 2.4 | 4.3 | 2.4 | 5.0 | 8.3 | 6.2 | |
| Quick Ratio | 3.6 | 6.9 | 7.2 | 13.6 | 21.6 | 21.5 | 2.2 | 3.9 | 2.1 | 4.9 | 8.2 | 6.1 | |
| Interest Coverage | · | · | · | · | · | -12564.8 | · | -671.2 | -24.8 | · | -16.6 | -17.7 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 1.2 | 1.3 | 0.9 | 0.6 | 0.8 | 1.4 | 1.3 | 3.1 | 5.7 | 3.8 | 4.0 | 4.1 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.66 | $1.25 | $1.56 | $2.38 | $3.35 | $3.48 | $0.85 | $2.63 | $0.12 | $0.64 | $1.64 | $0.44 | |
| Revenue / Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | · | · | $0.16 | $0.01 | $0.01 | $0.01 | $0.01 | |
| Cash Flow / Share | $-0.57 | $-0.79 | $-0.69 | $-0.78 | $-0.59 | · | · | $-5.66 | $-0.67 | $-1.03 | $-0.84 | $-0.67 | |
| Cash / Share | $0.26 | $0.77 | $0.48 | $0.37 | $0.28 | $3.56 | $1.19 | $2.99 | $0.16 | $0.45 | $2.27 | $1.44 | |
| EPS (TTM) | $-0.69 | $-0.95 | $-0.93 | $-0.89 | $-0.73 | $-1.08 | $-3.62 | $-8.26 | $-51.76 | $-1.37 | $-1.21 | $-0.88 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -13.2% | 40.0% | 26.4% | 7.5% | -1.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 15.4% | 23.9% | 10.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.1% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $593.0K | $683.0K | $488.0K | $386.0K | $359.0K | $366.0K | $244.6K | $378.3K | $505.4K | $381.1K | $312.8K | $280.2K | |
| Net Income TTM | $-46M | $-45M | $-41M | $-39M | $-28M | $-19M | $-16M | $-16M | $-25M | $-39M | $-27M | $-14M | |
| Market Cap | $192M | $289M | $66M | $63M | $252M | $662M | $11M | $12M | $1.18B | $4.64B | $11.56B | $5.86B | |
| P/E | -4.1 | -4.6 | -1.6 | -1.6 | -8.2 | -16.7 | -0.3 | -0.4 | -0.4 | -110.4 | -321.3 | -351.8 | |
| P/S | 323.7 | 422.7 | 135.5 | 162.0 | 702.5 | 1807.9 | 43.6 | 32.2 | 2331.4 | 12179.7 | 36961.4 | 20902.2 | |
| P/B | 4.2 | 3.5 | 0.9 | 0.6 | 1.8 | 5.2 | 1.5 | 1.2 | 181.1 | 234.8 | 237.4 | 701.4 | |
| P / Tangible Book | 4.2 | 3.5 | 0.9 | 0.6 | 1.8 | 5.2 | · | · | · | · | · | · | |
| P / Cash Flow | -5.1 | -7.7 | -2.1 | -1.8 | -10.9 | -40.6 | -0.8 | -0.9 | -50.6 | -149.5 | -522.7 | -460.1 | |
| P / FCF | -5.1 | -7.6 | -2.1 | -1.8 | -10.8 | -40.0 | -0.8 | -0.9 | -50.4 | -145.7 | -474.6 | -447.4 | |
| Earnings Yield | -24.6% | -21.9% | -62.8% | -63.6% | -12.2% | -6.0% | -291.9% | -259.8% | -231.9% | -0.91% | -0.31% | -0.28% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $104.0K | $41.0K | $243.0K | $120.0K | $121.0K | $109.0K | $150.0K | $165.0K | $163.0K | $205.0K | $156.0K | $141.0K | $108.0K | $83.0K | $128.0K | $93.0K | |
| SG&A Expense | $4M | $6M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | |
| Operating Expenses | $10M | $13M | $8M | $12M | $15M | $14M | $13M | $13M | $13M | $11M | $10M | $11M | $12M | $12M | $10M | $9M | |
| Operating Income | $-10M | $-13M | $-8M | $-12M | $-15M | $-14M | $-13M | $-13M | $-13M | $-11M | $-10M | $-11M | $-12M | $-12M | $-9M | $-9M | |
| Interest Income | $382.0K | $506.0K | $612.0K | $716.0K | $835.0K | $941.0K | $787.0K | $741.0K | $805.0K | $926.0K | $1M | $1M | $1M | $940.0K | $740.0K | $458.0K | |
| Other Non-op | $1.0K | $-1.0K | $-1.0K | $0 | $-1.0K | $7.0K | $-2.0K | $5.0K | $-38.0K | $-4.0K | $-13.0K | $21.0K | $5.0K | $-111.0K | $2M | $-36.0K | |
| Net Income | $-9M | $-12M | $-7M | $-11M | $-14M | $-13M | $-12M | $-12M | $-12M | $-10M | $-9M | $-10M | $-11M | $-11M | $-9M | $-9M | |
| EPS (Basic) | $-0.14 | $-0.18 | $-0.11 | $-0.17 | $-0.21 | $-0.20 | $-0.22 | $-0.25 | $-0.26 | $-0.22 | $-0.21 | $-0.22 | $-0.25 | $-0.25 | $-0.20 | $-0.20 | |
| EPS (Diluted) | $-0.14 | $-0.18 | $-0.11 | $-0.17 | $-0.21 | $-0.20 | $-0.22 | $-0.25 | $-0.26 | $-0.22 | $-0.21 | $-0.22 | $-0.25 | $-0.25 | $-0.20 | $-0.20 | |
| Shares (Basic) | 68,397,000 | 68,350,000 | · | 66,879,000 | 66,526,000 | 66,524,000 | · | 46,865,000 | 44,825,000 | 44,678,000 | · | 44,677,000 | 44,677,000 | 44,677,000 | · | 43,333,000 | |
| Shares (Diluted) | 68,397,000 | 68,350,000 | · | 66,879,000 | 66,526,000 | 66,524,000 | · | 46,865,000 | 44,825,000 | 44,678,000 | · | 44,677,000 | 44,677,000 | 44,677,000 | · | 43,333,000 | |
| EBITDA | $-10M | $-13M | · | · | $-15M | $-14M | · | $-13M | $-13M | $-11M | · | $-11M | $-12M | $-12M | · | · |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $9M | $17M | $10M | $11M | $24M | $51M | $13M | $26M | $19M | $22M | $15M | $19M | $15M | $16M | $19M | |
| Short-term Investments | $25M | $38M | $41M | $50M | $60M | $56M | $40M | $45M | $35M | $49M | $53M | $66M | $70M | $82M | $89M | $96M | |
| Receivables | $189.0K | $191.0K | $182.0K | $254.0K | $526.0K | $405.0K | $773.0K | $618.0K | $451.0K | $393.0K | $288.0K | $198.0K | $161.0K | $676.0K | $771.0K | $650.0K | |
| Prepaid Expense | $883.0K | $1M | $2M | $956.0K | $2M | $2M | $3M | $1M | $1M | $2M | $2M | $2M | $3M | $4M | $5M | $5M | |
| Current Assets | $36M | $47M | $60M | $62M | $74M | $83M | $95M | $59M | $62M | $70M | $77M | $84M | $93M | $102M | $111M | $120M | |
| PP&E (Net) | $450.0K | $491.0K | $578.0K | $666.0K | $743.0K | $805.0K | $898.0K | $993.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $5M | $5M | $5M | · | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $4M | $5M | $4M | · | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Other Non-current Assets | $927.0K | $844.0K | $549.0K | $549.0K | $401.0K | $257.0K | $69.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $184.0K | |
| Total Assets | $37M | $49M | $62M | $64M | $76M | $85M | $97M | $63M | $66M | $74M | $82M | $88M | $97M | $107M | $116M | $124M | |
| Accounts Payable | $4M | $5M | $8M | $2M | $6M | $4M | $5M | $5M | $5M | $5M | $2M | $2M | $3M | $3M | $2M | $1M | |
| Accrued Liabilities | $6M | $8M | $8M | $12M | $10M | $9M | $8M | $7M | $7M | $6M | $8M | $6M | $6M | $5M | $5M | $6M | |
| Current Liabilities | $11M | $14M | $16M | $15M | $17M | $13M | $13M | $13M | $13M | $12M | $10M | $9M | $9M | $8M | $8M | $8M | |
| Capital Leases | $0 | $0 | $102.0K | $284.0K | $464.0K | $640.0K | $813.0K | $979.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $11M | $14M | $16M | $15M | $17M | $14M | $14M | $14M | $14M | $13M | $12M | $11M | $11M | $10M | $10M | $10M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $478M | $477M | $475M | $472M | $470M | $468M | $467M | $422M | $413M | $410M | $409M | $408M | $407M | $406M | $405M | $404M | |
| Retained Earnings | $-452M | $-442M | $-430M | $-423M | $-412M | $-398M | $-384M | $-372M | $-361M | $-349M | $-340M | $-330M | $-320M | $-309M | $-298M | $-290M | |
| AOCI | $-62.0K | $-49.0K | $50.0K | $50.0K | $17.0K | $27.0K | $34.0K | $82.0K | $-97.0K | $-132.0K | $-67.0K | $-407.0K | $-431.0K | $-76.0K | $-395.0K | $-779.0K | |
| Stockholders' Equity | $27M | $35M | $45M | $49M | $59M | $71M | $83M | $49M | $52M | $61M | $70M | $78M | $87M | $97M | $106M | $113M | |
| Liabilities + Equity | $37M | $49M | $62M | $64M | $76M | $85M | $97M | $63M | $66M | $74M | $82M | $88M | $97M | $107M | $116M | $124M | |
| Shares Outstanding | 68,502,000 | 68,370,000 | 68,305,000 | 67,095,000 | 66,526,000 | 66,526,000 | 66,524,000 | 48,731,000 | 45,602,000 | 44,710,000 | 44,677,000 | 44,677,000 | 44,677,000 | 44,677,000 | 44,677,000 | 43,335,000 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $87.0K | $87.0K | $88.0K | $89.0K | $94.0K | $93.0K | $96.0K | $101.0K | $105.0K | $102.0K | $103.0K | $107.0K | $98.0K | $90.0K | $86.0K | $81.0K | |
| Stock-based Comp | $920.0K | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $909.0K | $955.0K | $2M | $1M | $1M | $1M | |
| Other Non-cash | · | $-2M | · | · | · | $-818.0K | · | · | · | $1M | · | · | · | $1M | · | · | |
| Operating Cash Flow | $-12M | $-12M | $-6M | $-11M | $-8M | $-13M | $-10M | $-10M | $-9M | $-8M | $-7M | $-8M | $-7M | $-9M | $-9M | $-7M | |
| CapEx | · | · | $0 | $18.0K | · | · | $0 | $0 | $0 | $80.0K | $8.0K | $315.0K | $251.0K | $8.0K | $75.0K | $448.0K | |
| Investing Cash Flow | $12M | $3M | $11M | $10M | $-5M | $-15M | $5M | $-9M | $14M | $5M | $14M | $4M | $11M | $7M | $7M | $5M | |
| Stock Issued | · | · | · | · | · | · | $44M | $7M | · | · | · | · | · | · | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | $7M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $149.0K | $105.0K | $3M | $25.0K | $0 | $3.0K | $44M | $7M | $2M | $107.0K | · | $0 | $0 | $0 | $0 | $75.0K | |
| Net Change in Cash | $653.0K | $-9M | $7M | $-649.0K | $-13M | $-27M | $38M | $-12M | $7M | $-3M | $6M | $-4M | $4M | $-1M | $-2M | $-2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-8M | · | · | · | $-9M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -9245.2% | -31341.5% | · | -9978.3% | -12212.4% | -13194.5% | · | -7637.0% | -7696.3% | -5333.2% | · | -7673.8% | -11303.7% | -14520.5% | · | · | |
| Net Margin | -8876.9% | -30109.8% | · | · | -11523.1% | -12324.8% | · | -7184.9% | -7225.8% | -4883.4% | · | -6901.4% | -10324.1% | -13521.7% | · | · | |
| EBITDA Margin | -9245.2% | -31129.3% | · | · | -12212.4% | -13109.2% | · | -7637.0% | -7696.3% | -5283.4% | · | -7673.8% | -11303.7% | -14412.0% | · | · | |
| ROA | -16.3% | -18.4% | · | · | -19.7% | -16.9% | · | -15.7% | -14.4% | -11.1% | · | -9.2% | -9.8% | -9.1% | · | · | |
| ROE | -21.7% | -23.4% | · | · | -25.1% | -20.4% | · | -18.6% | -17.0% | -12.7% | · | -10.2% | -10.8% | -9.9% | · | · |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 3.3 | · | · | 4.4 | 6.2 | · | 4.7 | 5.0 | 5.9 | · | 9.3 | 10.2 | 12.5 | · | · | |
| Quick Ratio | 3.2 | 3.2 | · | · | 4.3 | 6.0 | · | 4.7 | 4.9 | 5.7 | · | 9.0 | 9.8 | 12.0 | · | · |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | 0.3 | 0.1 | · | · | 0.2 | 0.3 | · | 0.4 | 0.5 | 0.4 | · | 0.3 | 0.3 | 0.1 | · | · |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.39 | $0.51 | · | · | $0.88 | $1.07 | · | $1.01 | $1.15 | $1.36 | · | $1.74 | $1.94 | $2.16 | · | · | |
| Revenue / Share | $0.00 | $0.00 | · | · | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | · | |
| Cash Flow / Share | · | $-0.18 | · | · | · | $-0.19 | · | · | · | $-0.17 | · | · | · | $-0.19 | · | · | |
| Cash / Share | $0.13 | $0.12 | · | · | $0.16 | $0.36 | · | $0.27 | $0.56 | $0.42 | · | $0.34 | $0.43 | $0.34 | · | · | |
| EPS (TTM) | $-0.60 | $-0.67 | · | $-0.80 | $-0.88 | $-0.93 | · | $-0.94 | $-0.91 | $-0.90 | · | $-0.92 | $-0.90 | $-0.89 | · | $-0.94 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $508.0K | $525.0K | · | $500.0K | $545.0K | $587.0K | · | $689.0K | $665.0K | $610.0K | · | $460.0K | $412.0K | $395.0K | · | $391.0K | |
| Net Income TTM | $-40M | $-45M | · | $-50M | $-51M | $-49M | · | $-43M | $-41M | $-40M | · | $-41M | $-40M | $-39M | · | $-39M | |
| Market Cap | $89M | $111M | · | · | $210M | $209M | · | $130M | $101M | $239M | · | $62M | $66M | $74M | · | · | |
| P/E | -2.2 | -2.4 | · | -2.6 | -3.6 | -3.4 | · | -2.8 | -2.4 | -5.9 | · | -1.5 | -1.6 | -1.9 | · | -1.6 | |
| P/S | 175.3 | 211.0 | · | · | 384.5 | 355.9 | · | 188.8 | 152.2 | 391.4 | · | 135.0 | 159.4 | 186.6 | · | · | |
| P/B | 3.4 | 3.2 | · | · | 3.6 | 2.9 | · | 2.6 | 1.9 | 3.9 | · | 0.8 | 0.8 | 0.8 | · | · | |
| P / Tangible Book | 3.4 | 3.2 | · | 2.8 | 3.6 | 2.9 | · | 2.6 | 1.9 | 3.9 | · | 0.8 | 0.8 | 0.8 | · | 0.6 | |
| P / Cash Flow | · | -9.0 | · | · | · | -16.3 | · | · | · | -30.8 | · | · | · | -8.5 | · | · | |
| Earnings Yield | -46.2% | -41.4% | · | -38.8% | -27.9% | -29.6% | · | -35.2% | -41.0% | -16.9% | · | -66.2% | -61.2% | -53.9% | · | -61.0% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $593.0K | $683.0K | $488.0K | $386.0K | $359.0K |
| 营业利润率 % | -8256.3% | -7123.1% | -9305.7% | -10337.3% | -8037.6% |
| 净收入 | $-46M | $-45M | $-41M | $-39M | $-28M |
| 稀释后每股收益 (EPS) | $-0.69 | $-0.95 | $-0.93 | $-0.89 | $-0.73 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 3.7 | 7.1 | 7.4 | 14.3 | 22.3 |
| 速动比率 | 3.6 | 6.9 | 7.2 | 13.6 | 21.6 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-38M | $-38M | $-31M | $-35M | $-23M |
机构持有人 (13F) 119 家申报者 · $36.6M 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
119
持有价值
$36.6M
新仓位
21
已退出持仓
29
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 21 (-3 与上一季度对比) | 29 (+16 与上一季度对比) | 34 (+2 与上一季度对比) | 28 (-9 与上一季度对比) | -6.3M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $10459059 | 3722085 | 28.57% | 股份 |
| Laurion Capital Management LP | $4027789 | 3098299 | 11.00% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $3764270 | 2895592 | 10.28% | 股份 |
| Pfizer Inc | $3014469 | 2411575 | 8.23% | 股份 |
| FRANKLIN RESOURCES INC | $1567544 | 1205803 | 4.28% | 股份 |
| BlackRock, Inc. | $1264735 | 972873 | 3.45% | 股份 |
| BLAIR WILLIAM & CO/IL | $1186267 | 912513 | 3.24% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $1066639 | 820062 | 2.91% | 股份 |
| TWO SIGMA ADVISERS, LP | $1013005 | 360500 | 2.77% | 股份 |
| GoalVest Advisory LLC | $831615 | 687285 | 2.27% | 股份 |
| UBS Group AG | $830309 | 638699 | 2.27% | 股份 |
| JANE STREET GROUP, LLC | $790270 | 607900 | 2.16% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $533783 | 410602 | 1.46% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $450260 | 346353 | 1.23% | 股份 |
| STATE STREET CORP | $430814 | 331395 | 1.18% | 股份 |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $321716 | 247474 | 0.88% | 股份 |
| MORGAN STANLEY | $319924 | 246095 | 0.87% | 股份 |
| Callan Capital, LLC | $318946 | 101575 | 0.87% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $296999 | 228461 | 0.81% | 股份 |
| CITADEL ADVISORS LLC | $239720 | 184400 | 0.65% | 买入期权 |
| MARSHALL WACE, LLP | $210879 | 162214 | 0.58% | 股份 |
| Bank of New York Mellon Corp | $210196 | 161689 | 0.57% | 股份 |
| NORTHERN TRUST CORP | $198738 | 152875 | 0.54% | 股份 |
| Cubist Systematic Strategies, LLC | $183140 | 88903 | 0.50% | 股份 |
| Avestar Capital, LLC | $176989 | 136145 | 0.48% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $174872 | 134517 | 0.48% | 股份 |
| Qube Research & Technologies Ltd | $163215 | 125550 | 0.45% | 股份 |
| GOLDMAN SACHS GROUP INC | $157076 | 120827 | 0.43% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $150979 | 116138 | 0.41% | 股份 |
| AlphaCore Capital LLC | $141041 | 108493 | 0.39% | 股份 |
| XTX Topco Ltd | $126620 | 97400 | 0.35% | 股份 |
| Squarepoint Ops LLC | $124917 | 96090 | 0.34% | 股份 |
| JANE STREET GROUP, LLC | $105300 | 81000 | 0.29% | 买入期权 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $93674 | 72057 | 0.26% | 股份 |
| Assenagon Asset Management S.A. | $87400 | 67231 | 0.24% | 股份 |
| WOLVERINE TRADING, LLC | $84448 | 40600 | 0.23% | 买入期权 |
| CAPSTONE INVESTMENT ADVISORS, LLC | $66547 | 51190 | 0.18% | 股份 |
| Mariner, LLC | $64163 | 49356 | 0.18% | 股份 |
| Creative Planning | $62526 | 48097 | 0.17% | 股份 |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | $62400 | 48000 | 0.17% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $61966 | 47666 | 0.17% | 股份 |
| IEQ CAPITAL, LLC | $58019 | 44630 | 0.16% | 股份 |
| Glenview Trust Co | $56066 | 43128 | 0.15% | 股份 |
| WOLVERINE TRADING, LLC | $52832 | 25400 | 0.14% | 卖出期权 |
| DIMENSIONAL FUND ADVISORS LP | $47645 | 36650 | 0.13% | 股份 |
| HighTower Advisors, LLC | $45193 | 34764 | 0.12% | 股份 |
| RHUMBLINE ADVISERS | $39083 | 30064 | 0.11% | 股份 |
| Point72 Asset Management, L.P. | $36901 | 28385 | 0.10% | 股份 |
| HSBC HOLDINGS PLC | $36825 | 28996 | 0.10% | 股份 |
| Quadrature Capital Ltd | $34927 | 26867 | 0.10% | 股份 |
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Acorn Bioventures, L.P., Acorn Capital Advisors, GP, LLC, Anders Hove ×2 申报 | 2023年1月26日 | · | 初始申报 | · | SEC |
| Bridger Management, LLC, Roberto Mignone | 2016年4月5日 | · | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 30 位内幕人士 · 13 位高管 · 13 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Mani Mohindru | Chief Executive Officer | 2026年7月14日 P | 59067 | 2 | 0 | $80062 |
| Mark Erlander | Chief Executive Officer | 2025年3月11日 A | 24481 | 0 | 0 | $0 |
| William J Welch | Chief Executive Officer | 2018年1月30日 M | 842645 | 0 | 0 | $0 |
| Joshua B Muntner | Chief Financial Officer | 2026年4月6日 A | · | 0 | 0 | $0 |
| James E. Levine | Chief Financial Officer | 2025年3月11日 A | 67716 | 0 | 0 | $0 |
| Steve Zaniboni | Former CFO | 2016年4月21日 M | 96968 | 0 | 0 | $0 |
| Ajay Aggarwal | Chief Operating Officer | 2026年4月27日 A | · | 0 | 0 | $0 |
| Vicki Kelemen | Exec. VP and COO | 2023年3月15日 A | 6053 | 0 | 0 | $0 |
| Tod Smeal | Chief Scientific Officer | 2026年4月14日 A | · | 0 | 0 | $0 |
| Brigitte Ute Lindsay | Chief Accounting Officer | 2026年2月13日 A | · | 0 | 0 | $0 |
| Fairooz Kabbinavar | Chief Medical Officer | 2025年3月11日 A | · | 0 | 0 | $0 |
| Katherine L Ruffner | Chief Medical Officer | 2022年3月9日 A | · | 0 | 0 | $0 |
| Matthew L. Posard | Chief Commercial Officer | 2016年1月4日 A | · | 0 | 0 | $0 |
| Gary W Pace | 董事 | 2026年7月14日 P | 2043661 | 2 | 0 | $1040036 |
| Lale White | 董事 | 2026年6月11日 A | 113788 | 0 | 0 | $0 |
| Renee P Tannenbaum | 董事 | 2026年6月11日 A | 20000 | 0 | 0 | $0 |
| Rodney S Markin | 董事 | 2026年6月11日 A | 23879 | 0 | 0 | $0 |
| James O Armitage | 董事 | 2026年6月11日 A | 13000 | 0 | 0 | $0 |
| Athena Countouriotis | 董事 | 2019年6月20日 A | · | 0 | 0 | $0 |
| Stanley Tennant | 董事 | 2018年6月8日 P | 28839 | 0 | 0 | $0 |
| Paul Billings | 董事 | 2018年1月23日 A | 23165 | 0 | 0 | $0 |
| Carl B Feldbaum | 董事 | 2015年3月17日 A | · | 0 | 0 | $0 |
| Christopher Mcguigan | 董事 | 2013年2月14日 A | · | 0 | 0 | $0 |
| Robert Merrill Hunter | 10% 所有者 | 2012年4月13日 P | 5065004 | 0 | 0 | $0 |
| John P Brancaccio | · | 2022年6月9日 J | 12260 | 0 | 0 | $0 |
| Gary S Jacob | · | 2021年6月10日 J | 21922 | 0 | 0 | $0 |
| Thomas Adams PHD | · | 2021年6月10日 J | 18875 | 0 | 0 | $0 |
| Antonius Schuh | · | 2016年1月4日 A | 20000 | 0 | 0 | $0 |
| Gabriel Cerrone | · | 2013年7月26日 A | 719526 | 0 | 0 | $0 |
| Kira Sheinerman | · | 2008年8月13日 P | 909090 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 4 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
CRDF 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 12 位分析师
买入
中位数目标
$6.00
+435.7%
2 16.7%
强烈买入
5 41.7%
买入
5 41.7%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
7 位分析师 · 2026-10-01平均目标 $5.81 +419.1%
← 低于所有目标
当前价格 $1.12
最低$1.20
平均值$5.81
最高$12.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | · |
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | · |
| CNXU | · | · | · | · | · | · |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | · |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | · |
| EQ | $95M | -4.0 | 13.9% | · | -133.1% | · |
| MNOV | $64M | -5.5 | · | -2928.8% | -27.1% | · |
| ICCC | · | -51.2 | 4.3% | · | · | · |
| ACRV | $76M | -1.2 | · | · | -61.0% | · |
| SERA | · | -4.4 | 5.2% | -39417.3% | -39.0% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 11, 2026 申报